Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: procedure (650), etiquette (1), practice (609)

Trastuzumab SC Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER TRASTUZUMAB SC Regimen Breast Cancer – Trastuzumab SC Indication Treatment of metastatic breast cancer over expressing HER2 - as
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-SC-Ver-1.1.pdf

Eribulin

Description: Chemotherapy Protocol BREAST CANCER ERIBULIN Regimen • Breast Cancer – Eribulin Indication • Treatment of locally advanced or metastatic breast cancer which has progressed
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEribulinVer1.2.pdf

Epirubicin (7) Ver1.1

Description: Chemotherapy Protocol BREAST CANCER EPIRUBICIN (7 day) Regimen Breast Cancer – Epirubicin (7 day) Indication Treatment of locally advanced or metastatic breast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEpirubicin7Ver11.pdf

Epirubicin (21) Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER EPIRUBICIN (21 day) Regimen Breast Cancer – Epirubicin (21 day) Indication Treatment of locally advanced or metastatic breast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEpirubicin21Ver11.pdf

Doxorubicin (7) Ver1.1

Description: Chemotherapy Protocol BREAST CANCER DOXORUBICIN (7 day) Regimen Breast Cancer – Doxorubicin (7 day) Indication Treatment of locally advanced or metastatic breast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastDoxorubicin7Ver11.pdf

Doxorubicin (21) Ver1.1

Description: Chemotherapy Protocol BREAST CANCER DOXORUBICIN (21 day) Regimen Breast Cancer – Doxorubicin (21 day) Indication Treatment of locally advanced or metastatic breast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastDoxorubicin21Ver11.pdf

Cyclophosphamide-Epirubicin Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN Regimen Breast Cancer – Cyclophosphamide-Epirubicin Indication Primary systemic (neoadjuvant) therapy of breast cancer Adjuvant therapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Ver-11.pdf

Cyclophosphamide-Doxorubicin Ver 1.1

Description: Regimen Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOXORUBICIN Breast Cancer – Cyclophosphamide-Doxorubicin Indication Primary systemic (neoadjuvant) therapy of breast cancer Adjuvant therapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Doxorubicin-Ver-1.1.pdf

Ibrutinib

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Ibrutinib • CLL – Ibrutinib Indication • NICE TA 429 recommends ibrutinib alone within its marketing authorisation as
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib.pdf

Topotecan (1,8,15)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8, 15) Regimen Ovary – Topotecan (1, 8, 15) Indication Second-line or subsequent treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan1815.pdf

271 to 280 of 698

Previous … 26 27 28 29 30 … Next